Acadia Healthcare has agreed to pay $179 million to settle a previously disclosed lawsuit filed on behalf of St. Clair County Employees’ Retirement System, according to a U.S. Securities and Exchange ...
Forbes contributors publish independent expert analyses and insights. I write on the intersection of disability and the U.S. workforce. Technology has opened new doors for Americans with disabilities, ...
Sept 24 (Reuters) - Acadia Pharmaceuticals (ACAD.O), opens new tab said on Wednesday it will discontinue development of its intranasal therapy to treat a rare genetic condition after it failed to show ...
An Oklahoma relocation program paid Californians $10,000 to move to the state, and some say they have never looked back, according to a Los Angeles Times report last month. The paper spoke with former ...
Redesigned for the 2024 model year on a larger three-row platform, the GMC Acadia rolls into 2026 with a new range-topping trim level but is otherwise little changed. The new Denali Ultimate trim caps ...
We may receive a commission on purchases made from links. While GE remotes are technically produced by a company called Jasco (as part of a licensing agreement with GE), the remotes are ...
GMC continues to expand its premium Denali Ultimate portfolio with the 2026 GMC Acadia Denali Ultimate, providing exclusive design, comfort, and technology features for its popular midsize crossover ...
View post: Rimac’s Newest 2,107-HP Hypercar Is the Rarest Nevera of Them All GMC’s most luxurious trim, the Denali Ultimate, has made its way to the midsize Acadia SUV for 2026, and like other models ...
For years, GMC's Denali trim level has represented the most expensive, nicest version of any given GMC model without stepping up to, well, a Cadillac. And as Denali has grown ever more critical to ...
At TopSpeed, William Clavey is Editor-at-Large, where he focuses on authority and exclusive content, reviews, news articles, features, and opinion pieces all while sharing his passion for everything ...
Acadia Pharmaceuticals (NASDAQ:ACAD) soared 28% after a court ruling in patent suit regarding its drug Nuplazid, which is used to treat Parkinson's disease. The court ruled that Aurobindo Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results